Trends in hepatitis C virus-associated mortality rates in Japan, 1998-2017

被引:4
|
作者
Hagiya, Hideharu [1 ]
Koyama, Toshihiro [6 ]
Deguchi, Matsuo
Minato, Yusuke [5 ]
Miura, Satomi [6 ]
Funahashi, Tomoko
Teratani, Yusuke
Zamami, Yoshito
Shinomiya, Kazuaki [7 ]
Kitamura, Yoshihisa [3 ]
Sendo, Toshiaki [4 ]
Hinotsu, Shiro [8 ]
Kano, Mitsunobu [2 ]
机构
[1] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Pharmaceut Biomed,Grad Sch Med Dent & Pharmaceut, Okayama, Japan
[2] Okayama Univ, Pharmaceut Biomed, Grad Sch Interdisciplinary Sci & Engn Hlth Syst, Okayama, Japan
[3] Shujitsu Univ, Sch Pharm, Dept Pharmacotherapy, Okayama, Japan
[4] Okayama Univ Hosp, Dept Pharm, Okayama, Japan
[5] Fujita Hlth Univ, Dept Microbiol, Sch Med, Toyoake, Aichi, Japan
[6] Tokushima Univ, Inst Biomed Sci, Dept Clin Pharmacol & Therapeut, Grad Sch, Tokushima, Japan
[7] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Pharmaceut Care & Clin Pharm, Tokushima, Japan
[8] Sapporo Med Univ, Dept Biostat & Data Management, Sapporo, Hokkaido, Japan
基金
日本学术振兴会;
关键词
death certificate; hepatitis C; mortality; vital statistics; VIRAL-HEPATITIS; NATIONAL-SURVEY; UNITED-STATES; B-VIRUS; COMBINATION; THERAPY; BURDEN; PEGINTERFERON; INFORMATION; SIMEPREVIR;
D O I
10.1111/jgh.15517
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aim The current prevalence of hepatitis C virus infection and hepatitis C virus-associated mortality in Japan falls short of the World Health Organization goal of viral hepatitis elimination by 2030. We aimed to evaluate the trends in hepatitis C virus-associated mortality in Japan. Methods This nationwide observational study used the Japanese Vital Statistics from 1998 to 2017 and included all Japanese hepatitis C virus-associated deaths (84 936) of adults aged >= 40 years. We calculated the crude and age-standardized mortality rates per 100 000 persons by age and sex. Joinpoint regression analysis was used to identify significant changing points in trends and to estimate the annual percentage changes and the average annual percentage changes for the entire study period. Results The crude mortality rate per 100 000 persons (annual death number) increased from 5.5 (3548) in 1998 to 7.0 (4843) in 2005 and decreased to 4.0 (3095) in 2017. By 2017, the crude mortality rates per 100 000 persons among men and women had dropped to 3.6 and 4.3, respectively. The age-standardized mortality rate was higher in women than in men. The average annual percentage change was -3.8% (95% confidence interval: -5.0 to -2.5). The declining trend was more rapid in men (-4.5%, 95% confidence interval: -5.3 to -3.6) than in women (-2.7%, 95% confidence interval: -3.8 to -1.6). Conclusions Trends in hepatitis C virus-associated mortality rates have declined in an accelerating manner in Japan, especially among men.
引用
收藏
页码:2486 / 2492
页数:7
相关论文
共 50 条
  • [21] Temporal Trends in Mortality in Patients with Systemic Sclerosis in Public Hospitals Across Mexico from 1998-2017
    Garcia-Carrasco, Mario
    Mendoza-Pinto, Claudia
    Etchegaray-Morales, Ivet
    Munguia-Realpozo, Pamela
    David Osorio-Pena, Angel
    Navarro-Milan, Olivia
    Jose Montiel-Jarquin, Alvaro
    Ayon-Aguilar, Jorge
    Mendez-Martinez, Socorro
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (06) : 610 - 616
  • [22] Virological features of hepatitis B virus-associated nephropathy in Japan
    Kusakabe, Atsunori
    Tanaka, Yasuhito
    Kurbanov, Fuat
    Goto, Kenji
    Tajiri, Hitoshi
    Murakami, Jun
    Okuse, Chiaki
    Yotsuyanagi, Hiroshi
    Joh, Takashi
    Mizokami, Masashi
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) : 1305 - 1311
  • [23] Time trends and geographical variation in prescribing of antibiotics in England 1998-2017
    Curtis, Helen J.
    Walker, Alex J.
    Mahtani, Kamal R.
    Goldacre, Ben
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (01) : 242 - 250
  • [24] The dilemma of treating hepatitis C virus-associated cryoglobulinemia
    Roccatello, Dario
    Fenoglio, Roberta
    Sciascia, Savino
    CURRENT OPINION IN RHEUMATOLOGY, 2019, 31 (05) : 499 - 504
  • [25] The hepatitis C virus-associated dysmetabolic syndrome - Reply
    Sheik, Muhammad Y.
    HEPATOLOGY, 2008, 48 (03) : 1019 - 1019
  • [26] HEPATITIS-C VIRUS-ASSOCIATED WITH MIXED CRYOGLOBULINEMIA
    MACRO, M
    PETITJEAN, J
    FREYMUTH, F
    BALLET, JJ
    LOYAU, G
    BRITISH JOURNAL OF RHEUMATOLOGY, 1994, 33 (06): : 593 - 594
  • [27] Clinicopathological Study on Hepatitis C Virus-associated Glomerulonephritis without Hepatitis C Virus in the Blood
    Yamabe, Hideaki
    Nakamura, Norio
    Shimada, Michiko
    Murakami, Reiichi
    Fujita, Takeshi
    Shimaya, Yuko
    Kitajima, Maiko
    Urushizaka, Mayumi
    INTERNAL MEDICINE, 2010, 49 (14) : 1321 - 1323
  • [28] Hepatitis C Virus-Associated Extrahepatic Manifestations: A Review
    Damien Sène
    Nicolas Limal
    Patrice Cacoub
    Metabolic Brain Disease, 2004, 19 : 357 - 381
  • [29] Hepatitis C virus-associated fulminant hepatic failure
    Farci, P
    Alter, HJ
    Shimoda, A
    Govindarajan, S
    Cheung, LC
    Melpolder, JC
    Sacher, RA
    Shih, JW
    Purcell, RH
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09): : 631 - 634
  • [30] Clinical characteristics of hepatitis C virus-associated retinopathy
    Abe, T
    Nakajima, A
    Satoh, N
    Koizumi, T
    Sakuragi, S
    Ono, T
    Komatsu, M
    Masamune, O
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 1995, 39 (04) : 411 - 419